TLR4 agonists as immunomodulatory agents

Journal of Endotoxin Research

Volumn 12, Issue 5, 2006, Pages 313-319

  Alderson, Mark R ^a   McGowan, Patrick ^a   Baldridge, Jory R ^a   Probst, Peter ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

Aminoalkyl glucosaminide phosphates; Immunomodulation; TLR4 agonists

Indexed keywords

AMINOGLUCOSAMINIDE PHOSPHATE; CD69 ANTIGEN; CELL SURFACE MARKER; CRX 525; CRX 527; GLUCOSAMINE DERIVATIVE; HEPATITIS B VACCINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOMODULATING AGENT; INTERFERON; MPL; PHOSPHORYL LIPID A; TOLL LIKE RECEPTOR 4 AGONIST; UNCLASSIFIED DRUG; DRUG DERIVATIVE; IMMUNOLOGIC FACTOR; IMMUNOLOGICAL ADJUVANT; LIPID A; PROTEIN MD 2; RESPIRATORY SYNCYTIAL VIRUS VACCINE; TOLL LIKE RECEPTOR 4;

ANIMAL EXPERIMENT; ARTICLE; BAGG ALBINO MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DOSE RESPONSE; DRUG STRUCTURE; EUROPE; HEPATITIS B; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; INFLUENZA; INNATE IMMUNITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; SALMONELLA MINNESOTA; STRUCTURE ACTIVITY RELATION; UPREGULATION; ANIMAL; CELL CULTURE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; DRUG POTENTIATION; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; METABOLISM; MOLECULAR MIMICRY; MONOCYTE; PHYSIOLOGY; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS INFECTION;

BACTERIA (MICROORGANISMS); MUS; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR MINNESOTA;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; CELLS, CULTURED; HUMANS; IMMUNITY, NATURAL; IMMUNOLOGIC FACTORS; LIPID A; LYMPHOCYTE ANTIGEN 96; MICE; MICE, INBRED BALB C; MOLECULAR MIMICRY; MOLECULAR STRUCTURE; MONOCYTES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS VACCINES; RESPIRATORY SYNCYTIAL VIRUSES; STRUCTURE-ACTIVITY RELATIONSHIP; TOLL-LIKE RECEPTOR 4;

EID: 34250640306     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1177/09680519060120050701     Document Type: Article

References (24)

1. Akira S. Mammalian Toll-like receptors. Curr Opin Immunol 2003; 15: 5-11.
2. Poltorak A., He X., Smirnova I. et al. Defective LPS signaling in C3H/ HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 1998; 282: 2085-2088.
3. Miyake K. Innate recognition of lipopolysaccharide by Toll-like receptor 4-MD-2. Trends Microbiol 2004; 12: 186-192.
4. Berger FM The effect of endotoxin on resistance to infection and disease. Adv Pharmacol 1967; 5: 19-46.
5. Neter E. Endotoxins and the immune response. Curr Top Microbiol Immunol 1969; 47: 82-124.
6. Myers KR, Truchot AT, Ward J., Hudson Y., Ulrich JT A critical determinant of lipid A endotoxic activity. In: Nowotny A, Spitzer JJ, Ziegler EJ. (eds) Cellular and Molecular Aspects of Endotoxin Reactions. Amsterdam: Elsevier, 1990; 145-156.
7. Thoelen S., Van Damme P, Mathei C. et al. Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system. Vaccine 1998; 16: 708-714.
8. Johnson DA, Sowell CG, Johnson CL et al. Synthesis and biological evaluation of a new class of vaccine adjuvants: Aminoalkyl glucosaminide 4-phosphates (AGPs). Bioorg Med Chem Lett 1999; 9: 2273-2278.
9. Cluff CW, Baldridge JR, Stäver AG et al. Synthetic Toll-like receptor 4 agonists stimulate innate resistance to infectious challenge. Infect Immun 2005; 73: 3044 - 3052.
10. Skeiky Yaw, Alderson MR, Ovendale PJ et al. Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein. J Immunol 2004; 172: 7618-7628.
11. Varga SM, Wissinger EL, Braciale TJ The attachment (G) glycoprotein of respiratory syncytial virus contains a single immunodominant epitope that elicits both Th1 and Th2 CD4+ T cell responses. J Immunol 2000; 165: 6487-6495.
12. Kulkarni AB, Collins PL, Bacik I. et al. Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus. J Virol 1995; 69: 1261-1264.
13. Saẗver AG, Da Silva Correia J., Evans JT et al. Structure-activity relationship of synthetic Toll-like receptor 4 agonists. J Biol Chem 2005; 279: 4440-4449.
14. Probst P., Skeiky YA, Steeves M., Gervassi A., Grabstein KH, Reed SG A Leishmania protein that modulates interleukin (IL)-12, IL-10 and tumor necrosis factor-alpha production and expression of B7-1 in human monocyte-derived antigen-presenting cells. Eur J Immunol 1997; 27: 2634-2642.
15. Collins PL, Chanock RM, Murphy BR Respiratory syncytial virus. In: Knipe DM, Howley PM. (eds) Field's Virology. Philadelphia, USA: Lippincott Williams & Wilkins, 2001; 21443-21486.
16. Rohde G., Wiethege A., Borg I. et al. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalization: A case-control study. Thorax 2003; 58: 37-42.
17. Malmgaard L. Induction and regulation of IFNs during viral infections. J Interferon Cytokine Res 2004; 24: 439-454.
18. Takeda K., Akira S. TLR signaling pathways. Semin Immunol 2004; 16: 3-9.
19. Hoebe K., Beutler B. LPS, dsRNA and the interferon bridge to adaptive immune responses: Trif, Tram, and other TIR adaptor proteins. J Endotoxin Res 2004; 10: 130-136.
20. Ahmad A., Alvarez F. Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis. J Leukoc Biol 2004; 76: 743-759.
21. Baldridge JR, McGowan P., Evans JT et al. Taking a toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents. Expert Opin Biol Ther 2004; 4: 1129-1138.
22. Goodier MR, Londei M. Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: A regulatory role of monocytes and IL-10. J Immunol 2000; 165: 139-147.
23. Gerosa F., Baldani-Guerra B., Nisii C., Marchesini V., Carra G., Trinchieri G. Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 2002; 195: 327-333.
24. Fort MM, Mozaffarian A., Stover AG et al. A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease. J Immunol 2005; 174: 6416-6423.